Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

MARLBOROUGH, Mass., April 22, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc. (NASDAQ:AKYA) ("Akoya"), The Spatial Biology Company, today announced that it will release financial results for the first quarter of

GlobeNewswireApr 22 16:05 ET

Piper Sandler Keeps Their Buy Rating on Akoya Biosciences (AKYA)

TipRanksApr 9 07:06 ET

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting With Case Studies Demonstrating Unprecedented Speed and Scale

MARLBOROUGH, Mass., April 05, 2024 (GLOBE NEWSWIRE) -- Akoya Biosciences, Inc., (Nasdaq: AKYA), The Spatial Biology Company, today announced it will highlight case studies featuring its Spatial Biol

GlobeNewswireApr 5 08:00 ET

Akoya Biosciences(AKYA.US) Officer Sells US$37,242.75 in Common Stocks

$Akoya Biosciences(AKYA.US)$ Officer McKelligon Brian sold 7,500 shares of Common Stocks on Mar 20, 2024 at an average price of $4.9657 for a total value of $37,242.75.Source: Announcement What is sta

moomoo NewsMar 22 18:36 ET

(SEC Amendment) Akoya Biosciences(AKYA.US) Officer Sells US$37,042.5 in Common Stocks

$Akoya Biosciences(AKYA.US)$ Officer McKelligon Brian sold 7,500 shares of Common Stocks on Mar 13, 2024 at an average price of $4.939 for a total value of $37,042.5.Source: Announcement What is state

moomoo NewsMar 22 18:31 ET

Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider

Bringing End-to-End Spatial Biology Solutions to Life Sciences Researchers for Advanced Spatial Proteomics AnalysisWALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven molecula

BusinesswireMar 19 07:00 ET